Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 137 clinical trials
Computer-Assisted Self-Administration of Ethanol

This study will test the reliability of a procedure for self-administering ethanol (alcohol) intravenously (through a vein), using a computer-assisted method. People ordinarily self-administer alcohol through drinking alcoholic beverages, but blood alcohol levels resulting from drinking vary greatly among individuals. For research on alcohol dependence and treatment, a tool for …

National Institutes of Health Clinical Center, 9000 Rockville Pike
 (9.7 away) Contact site
  • 21 Apr, 2021
  • 1 location
Siplizumab Combination Chemotherapy and Rituximab in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin Lymphoma

RATIONALE: Monoclonal antibodies, such as siplizumab and rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Drugs used in chemotherapy, such as etoposide, prednisone, vincristine , …

monoclonal antibodies
NCI - Center for Cancer Research
 (9.7 away) Contact site
  • 07 Nov, 2020
  • 1 location
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

Background Vitamin E is an antioxidant that reduces the damaging effects of oxygen in the body. Most American men (90%) and women (96%) do not get enough vitamin E from their diets; however, the amount of vitamin E needed by the body has been studied only in men, not women. …

oral hypoglycemic
hemoglobin a1c
heart failure
National Institutes of Health Clinical Center, 9000 Rockville Pike
 (9.7 away) Contact site
  • 13 May, 2021
  • 1 location
CellMist Autologous Cells to Treat Deep Second-Degree Burns

The overall purpose of this study is to evaluate the safety of the CellMist System in the treatment of deep second degree burns (IIB) in a prospective, multicenter, feasibility pilot study.

Washington MedStar Hospital
 (5.3 away) Contact site
  • 11 Jun, 2021
  • +3 other locations
First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults

Background Influenza (flu) is a contagious respiratory illness. It is caused by influenza viruses that infect the nose, throat, and sometimes the lungs. Vaccines are given to teach the body to prevent or fight infection. Researchers want to study a new vaccine to prevent the seasonal flu. Objective To see …

quadrivalent inactivated influenza vaccine
trivalent influenza vaccine
administration of vaccine
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 04 Jun, 2021
  • 1 location
Safety Tolerability and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

The purpose of this study is to evaluate the safety, tolerability, and efficacy of N-803, an IL-15 superagonist, with or without combination broadly neutralizing antibodies (bNAbs), to induce HIV-1 control during analytic treatment interruption (ATI).

HIV Vaccine
hiv-1 rna measurement
Whitman-Walker Institute, Inc. CRS
 (5.9 away) Contact site
  • 17 Jun, 2021
  • +1 other locations
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

This Phase I dose-escalation trial is designed to evaluate the safety of administering rapidly -generated tumor multi-antigen associated -specific cytotoxic T lymphocytes, to HSCT recipients (Arm A) or future HSCT recipients (Arm B) for the treatment of high-risk or relapsed or refractory hematopoietic malignancies. In addition to safety, this study …

Childrens National Medical Center
 (5.4 away) Contact site
  • 25 Jan, 2021
  • +1 other locations
A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors

The main purpose of this study are to determine the recommended Phase 2 dose (RP2D) regimen and the maximum tolerated dose, and to determine the safety of JNJ-63898081.

primary cancer
solid neoplasm
treatment regimen
measurable disease
NIH Clinical Center
 (9.7 away) Contact site
  • 03 Feb, 2021
  • +9 other locations
HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Background Some people with Amyotrophic Lateral Sclerosis (ALS) have a high level of the virus HERV-K in their blood. Researchers do not think this virus causes ALS. But they don t know why some people with ALS have a high level of it. They want to know if HERV-K can …

primary lateral sclerosis
National Institutes of Health Clinical Center, 9000 Rockville Pike
 (9.7 away) Contact site
  • 27 Jan, 2021
  • 1 location
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Background Some T-cell lymphomas and leukemias do not respond to standard treatment. Researchers hope to develop a treatment that works better than current treatments. Objective To test if interleukin (IL-5) combined with avelumab is safe and effective for treating certain cancers. Eligibility People ages 18 and older with relapsed T-cell …

mycosis fungoides
measurable disease
neutrophil count
adult t-cell leukemia
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 15 Feb, 2021
  • 1 location